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Results
One hundred twenty five patients (98%)
completed the whole designed radiotherapy.
Generally, 2-year local tumour control rate
(LTCR) in CAIR arm was 87% and in control-1
and control-2 arms respectively 40% and 67%
(p<0.0001 log rank). In aspect of tumour
localization and stage the LTCR was significantly
higher in CAIR arm than in controls and was
respectively as follows:
75% vs 10% and 33% in oral cavity,
86% vs 36% and 70% in oropharynx,
88% vs 50% and 80% in hypopharynx and
supraglottis;
100% vs 64% and 78% for T2,
94% vs 39% and 67% for T3,
66% vs 26% and 56% for T4.
There were 14% of grade III and IV radiation
morbidity in CAIR arm and 4% and 10% in
control-1 arms respectively.
Conclusion
The hight effectivness of CAIR
fractionation reflects the net effect of not only the
simple shortening the overall treatment time
by 2 weeks but also the exclusion treatment
weekend breaks.
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Introduction
Radiotherapy of malignant melanoma is
often performed in palliative therapy of
recurrences, metastases "in transit", bones and
brain metastases, to prevent bleeding and to
control the pain. Because of existence of large
"shoulder" in the radiation cell survival curve, high
fraction doses are used.
Material and Methods
27 patients with local lymph nodes
metastases or local recurrences of malignant
melanoma were palliatively irradiated. This group
included patients after surgical treatment and
disqualified for second operation. They were
irradiated with 9 MV photons or Co 60 gamma
rays, fraction dose was of 6 Gy ( 2 fractions
57
weekly), total dose was of 36 Gy (18 patients)
or 48 Gy (9 patients).
Results
Total remission was achieved in 14 cases,
partial remission in 8 cases, no remission we
observed in 5 cases. 5-year survival rate was
40,7% (11 patients). In the group of patients
irradiated with total dose of 36 Gy 5-year survival
rate was 44,4% ( 8 of 18 ), in other group irradiated
with total dose of 48 Gy 5-year survival rate was
33,3% (3 of 9).
Conclusion
Part of patients with malignant melanoma cured
with palliative radiotherapy can survive over
5 year.
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